Vaccines Knowledge-Based Study

Study notes

1. What Is a Vaccine?

   A vaccine is a biological preparation that provides acquired, active immunity to a specific infectious pathogen. It typically contains an agent that resembles a disease-causing microorganism, such as a weakened or killed pathogen, or specific surface molecules like proteins or polysaccharides.

   Mechanism of Action

   When administered, the vaccine introduces harmless antigens into the body. The host immune system recognizes these molecules as foreign and mounts a controlled immune response without causing the actual disease. Key events include:

   • Antigen Presentation: Antigen-presenting cells (such as dendritic cells and macrophages) engulf and process the introduced antigens, displaying fragments on major histocompatibility complex (MHC) proteins.
   • Lymphocyte Activation: Helper T cells recognize these complexes and activate both cytotoxic T cells (cell-mediated immunity) and B cells (humoral immunity).
   • Antibody Production: Activated B cells differentiate into plasma cells that secrete antibodies tailored to bind and neutralize the target pathogen.

   The Basis of Long-Term Protection

   The primary evolutionary purpose of vaccination is to establish immunological memory without the risk of severe pathology associated with natural infection.

   Primary Immune Response

   Upon initial exposure to an antigen via vaccination, the body produces a primary immune response:

   • There is a distinct latent (lag) phase of several days before detectable antibodies appear in the blood serum.
   • The initial antibody class produced is predominantly IgM, followed by class-switching to IgG.
   • The total concentration (titer) of circulating antibodies remains relatively low and gradually declines over time.

   Secondary Immune Response

   During the primary response, a subset of antigen-specific lymphocytes differentiates into long-lived memory B cells and memory T cells. When the individual later encounters the actual virulent pathogen, the secondary immune response is triggered:

   • The lag phase is significantly shorter (hours to a few days).
   • Antibody production occurs much more rapidly and reaches substantially higher concentrations.
   • The primary antibody isotype is IgG, which binds to the antigen with high affinity, clearing the pathogen before symptoms develop.

   Types of Vaccines

   Vaccine formulations differ based on how the pathogen or its antigens are processed and delivered to the immune system.

   • Live-Attenuated Vaccines: Contain living pathogens that have been weakened in laboratory conditions so they cannot cause disease in healthy individuals. They closely mimic natural infection and induce strong, long-lasting cellular and humoral responses (e.g., MMR, oral polio vaccine).
   • Inactivated (Killed) Vaccines: Contain pathogens killed by heat, chemicals, or radiation. Because the organism is dead, it cannot replicate or revert to a virulent state, but it generally requires booster doses to maintain protective immunity (e.g., rabies, injected polio vaccine).
   • Subunit, Recombinant, and Conjugate Vaccines: Utilize specific fragments of the pathogen, such as surface capsular polysaccharides or proteins, minimizing adverse reactions (e.g., hepatitis B, human papillomavirus).
   • Toxoid Vaccines: Use chemically inactivated bacterial toxins (toxoids) to teach the body to neutralize bacterial exotoxins rather than targeting the microorganism itself (e.g., tetanus and diphtheria toxoids).
   • Nucleic Acid Vaccines (mRNA / Viral Vector): Deliver genetic instructions (mRNA or DNA inside an adenovirus vector) encoding a harmless viral antigen, prompting the host's own cells to temporarily synthesize the antigen and present it to the immune system.

   Community-Level Protection

   Vaccination protects not only the vaccinated individual but also the broader population through a phenomenon known as herd immunity (community immunity).

   How Herd Immunity Works

   When a sufficiently high percentage of a population becomes immune to an infectious disease, the chain of transmission is disrupted:

   • Pathogens cannot easily spread from person to person because they encounter mostly resistant hosts.
   • This indirect protection shields vulnerable individuals who cannot be vaccinated, such as newborns, individuals with severe allergies to vaccine ingredients, and people with compromised immune systems.

   The Herd Immunity Threshold

   The proportion of immune individuals required to achieve herd immunity is termed the herd immunity threshold. This threshold depends directly on the basic reproduction number of the pathogen: highly contagious diseases require higher vaccination coverage to halt transmission within the community.